Medicon Hellas S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
11,397.00
11,033.80
11,456.00
13,010.00
12,704.40
13,771.30
Cost of Goods Sold (COGS) incl. D&A
3,710.50
3,325.80
3,213.00
3,684.20
3,460.60
3,875.80
Gross Income
7,686.50
7,708.10
8,243.00
9,325.80
9,243.80
9,895.60
SG&A Expense
5,365.50
5,656.50
6,012.20
6,944.90
7,449.40
7,720.30
EBIT
1,877.50
1,489.00
-
2,777.80
1,855.20
2,192.80
Unusual Expense
1.10
2.70
0.50
0.10
0.10
314.50
Non Operating Income/Expense
42.80
9.10
182.70
107.70
1,492.00
1,870.40
Interest Expense
1,910.00
1,599.10
1,778.90
1,873.30
1,713.70
561.60
Pretax Income
639.80
778.90
1,092.60
1,480.20
2,300.80
3,601.10
Income Tax
238.50
57.90
671.80
267.60
553.20
1,703.10
Consolidated Net Income
401.40
720.90
1,764.40
1,212.60
1,747.60
1,898
Net Income
93.00
699.40
1,674.70
1,165.80
1,717.70
1,830.30
Net Income After Extraordinaries
93.00
699.40
1,674.70
1,165.80
1,717.70
1,830.30
Net Income Available to Common
93.00
699.40
1,674.70
1,165.80
1,717.70
1,830.30
EPS (Basic)
0.02
0.15
0.38
0.26
0.39
0.41
Basic Shares Outstanding
4,377.60
4,629.80
4,419.60
4,419.60
4,419.60
4,419.60
EPS (Diluted)
0.02
0.15
0.38
0.26
0.39
0.41
Diluted Shares Outstanding
4,377.60
4,629.80
4,419.60
4,419.60
4,419.60
4,419.60
EBITDA
3,038.90
2,623.80
2,956.00
3,424.50
2,506.30
2,819.30
Other Operating Expense
443.60
562.60
15.00
396.80
60.70
17.50
Non-Operating Interest Income
630.60
882.60
443.50
468.10
667.50
414
Minority Interest Expense
308.40
21.50
89.80
46.80
29.90
67.70
About Medicon Hellas
View Profile
